Jonathan Zalevsky, an insider at Nektar Therapeutics (NASDAQ:NKTR), sold 180 shares of the company’s stock on February 18, 2024. The shares were sold at an average...
Herriot Tabuteau, the Chief Executive Officer of Axsome Therapeutics, Inc. (NASDAQ: AXSM), has sold 49,252 shares of the company’s stock in a transaction on December 2,...
Axsome Therapeutics, Inc. has announced that its CEO, Herriot Tabuteau, sold 49,252 shares of the company’s stock on December 2, 2023. The shares were sold at...
Blair William & Co. IL has expanded its investment in the iShares U.S. Medical Devices ETF (NYSEARCA:IHI) by 3.1% during the second quarter of 2023. This...
Major shareholder Jan Stahlberg has significantly increased his investment in DiaMedica Therapeutics, Inc. (NASDAQ: DMAC) by acquiring 59,788 shares on August 22, 2023. The shares were...
Ripple (XRP) is on the brink of a significant price movement, with analysts predicting a potential surge of 78% in the coming weeks. This increase could...
Titan Pharmaceuticals, Inc. experienced a remarkable surge in its stock price, rising 23% in after-hours trading on Tuesday, reaching $6.15 per share. This increase followed the...
Royce & Associates LP has taken a significant step by investing approximately $4.19 million in Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) during the first quarter of 2023....
Investment firm Edgestream Partners L.P. has expanded its portfolio by acquiring a new position in Oceaneering International, Inc. (NYSE:OII) during the first quarter of 2023. According...
